TRAIL Activates a Caspase 9/7-Dependent Pathway in Caspase 8/10-Defective SK-N-SH Neuroblastoma Cells with Two Functional End Points: Induction of Apoptosis and PGE2 Release

Neoplasia

Volumn 5, Issue 5, 2003, Pages 457-466

  Zauli, Giorgio ^a   Milani, Daniela ^b   Rimondi, Erika ^b   Baldini, Giovanna ^a   Nicolin, Vanessa ^a   Grill, Vittorio ^a   Secchiero, Paola ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

Caspases; Cell death; Neuroblastoma; Prostanoids; TRAIL

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE 10; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROSTAGLANDIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 0345690164     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1476-5586(03)80048-9     Document Type: Article

References (38)

1. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, and Smith CA (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673-82.
2. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, and Ashkenazi A (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271, 12687-690.
3. Mariani SM, and Krammer, PH (1998). Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 28, 973-82.
4. LeBlanc HN, and Ashkenazi, A (2003). Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ 10, 66-75.
5. Wang J, and Lenardo, MJ (2000). Roles of caspases in apoptosis, development, and cytokine maturation revealed by homozygous gene deficiencies. J Cell Sci 113, 753-57.
6. Frank S, Kohler U, Schackert G, and Schackert HK (1999). Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun 257, 454-59.
7. Hopkins-Donaldson S, Bodmer JL, Bourloud KB, Brognara CB, Tschopp J, and Gross N (2000). Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 60, 4315-319.
8. Xiao C, Yang BF, Asadi N, Beguinot F, and Hao C (2002). Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/ PEA-15 in glioma cells. J Biol Chem 277, 25020-25025.
9. Dorr J, Waiczies S, Wendling U, Seeger B, and Zipp F (2002). Induction of TRAIL-mediated glioma cell death by human T cells. J Neuroimmunol 122, 117-24.
10. Fulda S, Wick W, Weller M, and Debatin KM (2002). Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8, 808-15.
11. Haase GM, Perez C, and Atkinson JB (1999). Current aspects of biology, risk assessment, and treatment of neuroblastoma. Semin Surg Oncol 16, 91-104.
12. Secchiero P, Gonelli A, Celeghini C, Mirandola P, Guidotti L, Visani G, Capitani S, and Zauli G (2001). Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. Blood 98, 2220-228.
13. Secchiero P, Gonelli A, Ciabattoni G, Melloni E, Grill V, Rocca B, Delbello G, and Zauli G (2002). TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE2 production in cells of the myeloid lineage. J Leukoc Biol 72, 986-94.
14. Milani D, Zauli G, Rimondi E, Celeghini C, Marmiroli S, Narducci P, Capitani S, and Secchiero P (2003). TNF-related apoptosis-inducing ligand (TRAIL) sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. J Neurochem 86, 126-35.
15. Dorr J, Bechmann I, Waiczies S, Aktas O, Walczak H, and Krammer PH (2002). Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J Neurosci 22, 1-5.
16. Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR, Ho R, Ikegaki N, and Brodeur GM (2001). Resistance to tumor necrosis factor-apoptosis-inducing ligand-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61, 1314-319.
17. Teitz T, Wei T, Valentine MB, Vanin EF, Grenet J, Valentine VA, Behm T, Look T, Lahti JM, and Kidd VJ (2000). Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6, 529-35.
18. Kischkel FC, Lawrence DA, Tinel A, LeBlanc H, Virmani A, Schow P, Gazdar A, Blenis J, Arnott D, and Ashkenazi A (2001). Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276, 46639-646.
19. Harada K, Toyooka S, Shivapurkar N, Maitra A, Reddy JL, Matta H, Miyajima K, Timmons CF, Tomlinson GE, Mastrangelo D, Hay RJ, Chaudhary PM, and Gazdar AF (2002). Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res 62, 5897-901.
20. Thorburn J, Bender LM, Morgan MJ, and Thorburn A (2003). Caspase- and serine protease-dependent apoptosis in the death domain of FADD in normal epithelial cells. Mol Biol Cell 14, 67-77.
21. Smith WL, and DeWitt, DL (1996). Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol 62, 167-215.
22. Chang YW, Jakobi R, McGinty A, Foschi M, Dunn MJ, and Sorokin A (2000). Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity. Mol Cell Biol 20, 8571-579.
23. McGinty A, Chang YW, Sorokin A, Bokemeyer D, and Dunn MJ (2000). Cyclooxygenase-2 expression inhibits trophic withdrawal apoptosis in nerve growth factor-differentiated PC12 cells. J Biol Chem 275, 12095-101.
24. Han JA, Kim II, J, Ongusaha PP, Hwang DH, Ballou LR, Mahal A, Aaronson SA, and Lee SW 2002. p53-mediated induction of COX-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J 21, 5635-644.
25. 2 synthesis in human neuroblastoma cells: involvement of p38 mitogen-activated protein kinase and nuclear factor-kB. J Neurochem 75, 2020-2028.
26. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, and Vane JR (1993). Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cycloxygenase. Proc Natl Acad Sci USA 90, 11693-701.
27. Tsujii M, and DuBois RN (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
28. 2 in human colon cancer cells. Cancer Res 58, 362-66.
29. Un MT, Lee RC, Yang PC, Ho FM, and Kuo ML (2001). Cyclooxygenase-2 inducing a Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1. 0 cells: involvement of PI 3-K/Akt pathway. J Biol Chem 276, 48997-49002.
30. Chan TA, Morin PJ, Vogelstein B, and Kinzler KW (1998). Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci USA 95, 681-86.
31. 2 secretion by human neuroblastoma cells: implications for Alzheimer's disease. Exp Gerontol 36, 559-70.
32. Chen D, Balyakina EV, Lawrence M, Christman BW, and Meyrick B (2003). Cyclooxygenase is regulated by ET-1 and MAPKs in peripheral lung microvascular smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 284, L614-621.
33. Guise S, Braguer D, Carles G, Delacourte A, and Briand C (2001). Hyperphosphorylation of Tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells. J Neurosci Res 63, 257-67.
34. Matthay KK (1997). Neuroblastoma: biology and therapy. Oncology 11, 1857-866.
35. Kim S, Kang J, Hu W, Evers BM, and Chung DH (2003). Geldanamycin decreases Raf-1 and Akt levels and induces apoptosis in neuroblastomas. Int J Cancer 103, 352-59.
36. Hida T, Kozaki K, Muramatsu H, Masuda A, Shimizu S, Mitsudomi T, Sugiura T, Ogawa M, and Takahashi T (2000). Cycloxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res 6, 2006-2011.
37. Hsu AL, Ching TT, Wang DS, Song X, Rangnekar VM, and Chen CS (2000). The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J Biol Chem 275, 11397-403.
38. Ishikawa Y, and Kitamura M (1999). Dual potential of extracellular signal-regulated kinase for the control of cell survival. Biochem Biophys Res Commun 264, 696-701.